Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis

View/Open

Supporting information (63.31Kb)

Publication Date

2018-04

ICR Author

Marsden,

Author

Ogungbenro, K

Patel, A

Duncombe, R

Nuttall, R

Clark, J

Lorigan, P

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/1350

Collections

• Other ICR Research

Version of record

10.1002/cpt.875

License start date

2018-04

Citation

Clinical Pharmacology & Therapeutics, 2018, 103 (4), pp. 582 - 590